FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer

Na Liu1, Anran Wang2, Mengen Xue2

  • 1Department of Radiotherapy and Oncology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China. 2697075944@qq.com.

Cell Death Discovery
|April 11, 2024
PubMed

Insights

Forkhead Box A1 (FOXA1) and FOXA2 are key transcription factors in biological processes. This review explores their roles in steroid hormone cancers and potential therapeutic targeting strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Endocrinology

Background:

  • Forkhead Box A1 (FOXA1) and FOXA2 are pioneering transcription factors crucial for gene expression.
  • They regulate vital biological processes like organogenesis, metabolism, proliferation, and drug resistance.
  • FOXA1 and FOXA2 can exhibit antagonistic, synergistic, or complementary functions.

Purpose of the Study:

  • To elucidate the molecular mechanisms of FOXA1 and FOXA2 in steroid hormone-induced cancers.
  • To review the clinical relevance of FOXA1 and FOXA2 in these malignancies.
  • To explore therapeutic strategies targeting FOXA1 and FOXA2 or their upstream regulators.

Main Methods:

  • Literature review focusing on molecular mechanisms and clinical relevance.
  • Analysis of the roles of FOXA1 and FOXA2 in cancer development and progression.
  • Exploration of potential therapeutic interventions and targeting strategies.

Main Results:

  • FOXA1 and FOXA2 play significant roles in the development and progression of steroid hormone-induced cancers.
  • Their complex interactions influence various cellular processes relevant to malignancy.
  • Targeting FOXA1/FOXA2 or their upstream regulators presents a promising therapeutic avenue.

Conclusions:

  • Understanding the dual roles of FOXA1 and FOXA2 is critical for developing effective cancer therapies.
  • Targeting these transcription factors offers a novel approach to treating steroid hormone-related cancers.
  • The drug untargetability of FOXA1/FOXA2 necessitates focus on upstream regulators for therapeutic intervention.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K